DEC 11, 2018 11:00 AM PST

Biosensors developed that can detect cancer's metastatic ability

WRITTEN BY: Heba El Wassef

Researchers in University of California San Diego School of Medicine have developed a biosensor that can detect whether a cancer cell will spread in the future or not, which will help in developing a personalized treatment for each cancer patient based on whether the tumor will further metastasize or not. The paper was published in iScience.

“Cancer would not be so devastating if it did not metastasize,” said Pradipta Ghosh, MD, professor in the UC San Diego School of Medicine departments of Medicine and Cellular and Molecular Medicine, director of the Center for Network Medicine and senior study author.

Metastasis is the leading cause of death in cancer patients, it could be detected after its occurrence, but there was no way to detect the potentiality of it happening in the future. The newly developed fluorescence resonance energy transfer (FRET) biosensors can monitor multiple signals that drive metastasis; upon sensing those signals a fluorescent signal will be turned on only if there is high potentiality for metastasis and this signal can be measured.

A tumor cell that has acquired high metastatic potential during chemotherapy lights up with high FRET biosensor readout, whereas the cells that are sensitive to chemotherapy (and hence, low potential) stays dark. Credit: UC San Diego News Center

The researchers lead by Dr. Pradipta Ghosh started looking for a biomarker that can act as a signal that will be detected by FRET biosensors, a cancer phosphoprotein that is absent in normal cells, involved in cellular processes, bind or modulate actin which is essential in cancer invasion, and is involved in cancer migration. They identified a particular protein and its unique modification that is only present in cancer cells called tyrosine-phosphorylated CCDC88A (GIV/Girdin) that fits all the criteria needed.

The team used FRET biosensors and microscopes to monitor the modifications of GIV, and a fluorescent signal was turned on reflecting a high potentiality for metastasis. These biosensors can detect and measure the metastatic potential of a single cancer cell in any type of cancer and can remain effective despite the changes in cancer cells occurring during disease progression or as a result of anti-cancer drugs.

The development of FRET biosensors will help to develop a personalized treatment based on each patients condition, for example sparing patients whose cancers do not have metastatic potential from unnecessary therapies while patients whose cancers are believed to metastasize can be treated with precision medicine to target the metastatic cells.

“It is like looking at a Magic 8 Ball, but with a proper yardstick to measure the immeasurable and predict outcomes,” said Ghosh. “We have the potential not only to obtain information on single cell level but also to see the plasticity of the process occurring in a single cell. This kind of imaging can be used when we are delivering treatment to see how individual cells are responding.”

The sensors need further improvements before being used for in vivo imaging studies as advised by the research team, but they have the potential to become a breakthrough in cancer biology.

Watch the video below to understand more about biosensors.

Sources: ScienceDaily via UC San Diego

About the Author
  • A master student in Biochemistry and Molecular biology with experience in Education and Research. I am passionate about scientific research and passing my knowledge to others to help them learn about the latest in science by teaching, writing and volunteering in scientific events.
You May Also Like
JAN 20, 2020
Neuroscience
JAN 20, 2020
Ovarian Cancer Protein Accelerates Alzheimer's Neurodegeneration
Around 21,000 people in the US are diagnosed with ovarian cancer every year, while an estimated 5.8 million Americans have Alzheimer’s. Now, research...
FEB 19, 2020
Clinical & Molecular DX
FEB 19, 2020
Forget complicated scans - ovarian cancer can be detected in the blood
Results from clinical trials performed in Melbourne, Australia have revealed the diagnostic potential of a new test for ovarian cancer. Instead of using co...
FEB 24, 2020
Drug Discovery & Development
FEB 24, 2020
Leukemic Drugs May Target Lung Cancer
Two approved therapeutics for treating leukemia are currently being investigated for treatment-resistant lung cancer.  The findings were based on a li...
MAR 15, 2020
Cancer
MAR 15, 2020
The racism behind cancer
Researchers from the University of Colorado Cancer Center have made strides in understanding the reasons behind disparities in outcomes for cancer patients...
MAR 24, 2020
Clinical & Molecular DX
MAR 24, 2020
Ultra sensitive cancer diagnostic detects DNA "fingerprints" in liquid biopsies
  Researchers from the Broad and Dana-Farber Cancer Institutes have developed a diagnostic technology that can monitor for the presence of recurring c...
MAR 28, 2020
Cancer
MAR 28, 2020
The Not So Minor Genetic Players in Head and Neck Cancers
Head and neck squamous cell carcinomas (HNSCC) are among the most prevalent cancers among smokers, linked to alcohol consumption, and the human papillomavi...
Loading Comments...